These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28257228)

  • 61. Anti-KANNO: a novel alloantibody against a red cell antigen of high frequency.
    Kawabata K; Uchikawa M; Ohto H; Yasuda H; Tsuneyama H; Tsuchida H; Ito S
    Transfus Med Rev; 2014 Jan; 28(1):23-8. PubMed ID: 24485899
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Erythrocyte sensitization and anemia due to isoantibodies in lyophilized pooled plasma.
    Oberman HA; Barnes BA; Ginther PL
    JAMA; 1966 Oct; 198(3):323-5. PubMed ID: 5952940
    [No Abstract]   [Full Text] [Related]  

  • 64. [Hemolytic transfusion reaction due to interdonor incompatibility].
    Skov F; Dybkjaer E; Taaning E; Thygesen V; Drachmann O
    Ugeskr Laeger; 1985 Dec; 147(51):4205-6. PubMed ID: 4090069
    [No Abstract]   [Full Text] [Related]  

  • 65. Pregnancy outcome in mothers who develop Kell antibodies.
    Farr V; Gray E
    Scott Med J; 1988 Aug; 33(4):300-3. PubMed ID: 3055288
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Hemolysis induced by anti-JKa antibodies].
    Lewinski U; Ben-Porath D; Weigel K
    Harefuah; 1982 May; 102(9):378. PubMed ID: 7160726
    [No Abstract]   [Full Text] [Related]  

  • 67. A delayed hemolytic transfusion reaction due to anti-Cob.
    Squires JE; Larison PJ; Charles WT; Milner PF
    Transfusion; 1985; 25(2):137-9. PubMed ID: 3984006
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Severe hemolytic transfusion due to an anti-S].
    Schneider W; Clauberg G
    Med Welt; 1966 Jun; 26():1429-30. PubMed ID: 5962716
    [No Abstract]   [Full Text] [Related]  

  • 69. Delayed hemolytic transfusion reaction with four antibodies undetected by pretransfusion tests.
    Moncrieff RE; Thompson WP
    Am J Clin Pathol; 1975 Aug; 64(2):251-3. PubMed ID: 1155388
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Frequently encountered problems in transfusion medicine when managing patients with antibodies.
    Neurath D; Moulds J
    Transfus Apher Sci; 2009 Jun; 40(3):183-4. PubMed ID: 19409849
    [No Abstract]   [Full Text] [Related]  

  • 71. [Compatibility tests and pre-transfusion precautions].
    Andre A
    Acta Anaesthesiol Belg; 1970; 21(1):69-87. PubMed ID: 4997382
    [No Abstract]   [Full Text] [Related]  

  • 72. Potentially clinically significant anti-Di
    Branch DR; Holton MB; Ison T; Cote J; Dube C; Lau W
    Transfusion; 2021 Jan; 61(1):331-332. PubMed ID: 33616959
    [No Abstract]   [Full Text] [Related]  

  • 73. Biological significance of the York, Cost, McCoy and Knops alloantibodies.
    Molthan L
    Rev Fr Transfus Immunohematol; 1982 Apr; 25(2):127-47. PubMed ID: 7100752
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Summary of the clinical significance of blood group alloantibodies.
    Reid ME; Oyen R; Marsh WL
    Semin Hematol; 2000 Apr; 37(2):197-216. PubMed ID: 10791888
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunohematology.
    Virella G; Spivey MA
    Immunol Ser; 1990; 50():375-94. PubMed ID: 2091762
    [No Abstract]   [Full Text] [Related]  

  • 76. [Transfusion reaction due to natural isoantibodies of anti-N specificity].
    Delmas-Marsalet Y; Chateau G; Foissac-Gegoux P; Goudemand M
    Transfusion (Paris); 1967; 10(4):369-72. PubMed ID: 5584694
    [No Abstract]   [Full Text] [Related]  

  • 77. [Immunological safety of transfusion].
    Muller JY; Chiaroni J; Garraud O
    Presse Med; 2015 Feb; 44(2):200-13. PubMed ID: 25578545
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Anti-Tja antibody as a transfusion problem in surgery with a high risk of bleeding].
    Barbolla L; Campano F; Cabrera P; Zabala P; Sanjuan I; Fernández MN
    Sangre (Barc); 1987; 32(6):731-4. PubMed ID: 3438811
    [No Abstract]   [Full Text] [Related]  

  • 79. Can we "terminate" alloimmune platelet transfusion refractoriness?
    Vassallo RR; Norris PJ
    Transfusion; 2016 Jan; 56(1):19-22. PubMed ID: 26756708
    [No Abstract]   [Full Text] [Related]  

  • 80. [Allergic transfusion reactions unrelated to blood groups].
    PREUNER R
    Bibl Haematol; 1956; 5():8-16. PubMed ID: 13373738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.